# AL-15469A for the Treatment of Bacterial Conjunctivitis

> **NCT00332293** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 695 (actual)

## Conditions studied

- Bacterial Conjunctivitis

## Interventions

- **DRUG:** Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5%
- **DRUG:** Moxifloxacin hydrochloride ophthalmic solution 0.5% as base

## Key facts

- **NCT ID:** NCT00332293
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 695 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332293, "AL-15469A for the Treatment of Bacterial Conjunctivitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00332293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*